Henry Review vs PlexusDx (2026): GLP-1 Provider Cost & Care Analysis | PlexusDx

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you’ve been researching Henry for cash-pay GLP-1 weight loss, the headline number is $297/month month-to-month for injectable compounded semaglutide, all-inclusive — medication, consultation, and shipping in one bill (the advertised “$197/month” is Henry’s 12-month prepaid-in-full rate). That positions Henry in the mid-to-upper tier of compounded telehealth pricing, well below FDA-approved branded routes but meaningfully higher than the lowest-cost compounded protocols on the market. This Henry review walks through what Henry actually delivers, where the $297/month figure lands on annualized cost, the compounded vs FDA-approved branded medication question, and where PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 Protocol sit relative to Henry — because the choice between Henry and a PlexusDx Weight Management Protocol isn’t about which company is “better.” It’s about total cost, dose flexibility, oversight model, and whether genetics inform titration before week one.

Henry at a glance — what the $297/month buys

Henry is a telehealth weight-loss provider operating since 2023, dispensing injectable compounded semaglutide at $297/month month-to-month; its tirzepatide is an oral dissolving tablet only (3-month supply, $1,047, or $891 paid in full), as of July 2026 — Henry does not offer injectable tirzepatide. The semaglutide bundle includes the medication, the initial video or phone consultation with a licensed physician, follow-up consultations, supplies, and shipping. There is no separate membership fee, and $0 is charged until a prescription is written. On the month-to-month plan, cancellation is allowed at any time before the next billing cycle; on multi-month prepaid plans, Henry’s terms state that cancelling early may require paying out the remaining balance unless you are medically unable to continue. Shipping is cold-chain and typically arrives within 3–5 business days after the prescription is approved. Henry serves most U.S. states but is not available in every jurisdiction. The model is straightforward: all-inclusive subscription pricing, both molecules available (semaglutide by injection or sublingual tablet, tirzepatide as an oral tablet), comprehensive medical oversight, no add-ons or upsells in the standard plan. For a patient who wants a single all-in price and doesn’t want to think about pharmacy fulfillment separately from the prescriber, Henry is a clean offering — the trade-off is that the $297/month price point sits above the entry tier of the compounded GLP-1 market.

Henry pricing math — the real annualized cost

At $297/month month-to-month, Henry’s injectable compounded semaglutide runs $3,564/year all-in; prepaid plans lower it (6-month $1,482, about $247/month; 12-month $2,364 paid in full — the advertised “$197/month” rate). Henry’s oral tirzepatide tablets are sold as a 3-month supply at $1,047 ($891 paid in full), with no month-to-month rate published. That number is comparable to other comprehensive-care compounded platforms and well below FDA-approved branded routes (Wegovy and Zepbound list price ~$1,000–$1,350/month before insurance; Lilly Direct’s Zepbound self-pay vials run ~$499/month, or ~$5,988/year). For comparison against the PlexusDx Weight Management Protocols using identical compounded molecules: Microdose GLP-1 Protocol is $129/month flat ($1,548/year — roughly $2,016/year less than Henry), Semaglutide Injection runs $189/mo ($2,268/year month-to-month, less on multi-month plans), Tirzepatide Injection runs $289/mo ($3,468/year), and GLP-Squared dual-compound therapy is $289/mo ($3,468/year). Every PlexusDx protocol in this comparison prices below Henry’s $297 month-to-month semaglutide rate. If you add the Precision Peptide Genetic Test at $99 as an add-on after your first month, the genetic-baseline-included PlexusDx total still lands below Henry’s $3,564/year on the Microdose and Semaglutide Injection protocols, and within a few dollars of it on the $289/mo protocols.

Compounded vs FDA-approved branded — what Henry actually dispenses

This is the substantive medication question and it applies to both Henry and PlexusDx. Henry’s standard plan dispenses compounded semaglutide (injectable or sublingual) and compounded tirzepatide (oral dissolving tablets only, as of July 2026) — formulations prepared by 503A or 503B licensed compounding pharmacies under U.S. compounding regulations. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products; they are pharmacy-prepared versions of the same active ingredients found in the FDA-approved branded products (Wegovy, Ozempic, Mounjaro, Zepbound). The same is true of PlexusDx Weight Management Protocols — Semaglutide Injection and Tirzepatide Injection use compounded versions from licensed U.S. compounding pharmacies. Neither Henry nor PlexusDx dispenses Wegovy or Zepbound directly; if branded medication is what you need, both routes will redirect you toward a different telehealth provider (e.g., Ro, Sesame, Walgreens, or Lilly Direct). The compounded vs branded choice isn’t about whether semaglutide or tirzepatide works — the active molecules are the same. It’s about the FDA approval status of the finished product, supply consistency, and which regulatory framework governs your specific medication.

How Henry works — intake, prescription, delivery

Henry’s flow is standard for the comprehensive-care telehealth tier. Step one is the intake questionnaire ($0 is due until a prescription is written), which captures medical history, current medications, weight-loss goals, and contraindication screening (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe pancreatitis, severe gallbladder disease, pregnancy, and so on). Step two is a video or phone consultation with a licensed physician who reviews the intake, discusses goals, and selects the molecule (semaglutide or tirzepatide) and starting dose. Step three is prescription routing to the partner compounding pharmacy. Step four is cold-chain shipping in 3–5 business days. Follow-up consultations are included in the monthly fee, allowing dose escalation conversations and side-effect management without an extra bill. PlexusDx Weight Management Protocols use a similar async or live-consult intake (5 states require a live consultation rather than async), with the addition of an optional genetic baseline before titration begins.

Pros and cons of Henry — an honest read

Pros. All-inclusive flat pricing — no surprise pharmacy bills, no a-la-carte consultation charges. Both molecules available on a single platform. No membership fee, $0 due at signup, and month-to-month billing that can be cancelled before the next cycle. Fast cold-chain shipping. Comprehensive medical oversight via video or phone consultation rather than purely async chat. Cons. Higher monthly cost than entry-tier compounded GLP-1 providers — the Microdose GLP-1 Protocol at $129/month flat is less than half Henry’s price, and Semaglutide Injection at $189/mo sits below Henry across its full dose range. Not available in every U.S. state. No insurance billing — cash-pay only. No genetic baseline included; titration starts from population averages and adjusts based on subjective tolerability. No FDA-approved branded option (Wegovy, Zepbound) available through the standard plan — if you specifically want branded medication, Henry isn’t the route. PlexusDx shares Henry’s cash-pay, no-membership, no-branded-option positioning but undercuts on entry-tier price and adds an optional genetic component.

Where PlexusDx differs — dose flexibility and a genetic baseline

The two structural differences between Henry and PlexusDx are dose-format diversity and the genetic baseline. Henry lists $297/month month-to-month for injectable compounded semaglutide; its tirzepatide is an oral dissolving tablet only (3-month supply, $1,047, or $891 paid in full), as of July 2026 — Henry does not offer injectable tirzepatide. PlexusDx offers six protocols across four mechanism classes: Microdose GLP-1 Protocol ($129/mo flat, four delivery variants — capsule, troche, lozenge, sublingual), Semaglutide Oral (from $289/mo, 3mg–24mg daily across six dose levels), Semaglutide Injection ($189/mo, 0.25mg–2.0mg weekly across five dose levels), Tirzepatide Injection ($289/mo, 2.5mg–15mg weekly across six dose levels), Tirzepatide Oral ($349/mo, 5mg–25mg daily across seven dose levels), and GLP-Squared ($289/mo, compounded semaglutide + tirzepatide stack across six dose pairs). The dose-format diversity matters because not every patient tolerates a weekly injection — for needle-averse patients, oral or microdose options remove a structural barrier. The Precision Peptide Genetic Test ($298 standalone, or $99 add-on after your first month) maps 48 genes and 57 variants across 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — so your titration is anchored to a measurable baseline rather than to population averages.

Safety profile — what applies to Henry, PlexusDx, and any GLP-1 route

The safety profile is class-wide and applies regardless of which telehealth provider you use. Common side effects of GLP-1 receptor agonists include nausea, vomiting, diarrhea, constipation, abdominal pain, and headache — usually most pronounced during dose escalation and improving with titration adjustment. Less common but documented adverse events include pancreatitis, gallbladder disease (cholelithiasis and cholecystitis), and acute kidney injury related to dehydration from severe nausea or vomiting. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies; both molecules are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). Tirzepatide’s GIP/GLP-1 dual-agonist mechanism is associated with somewhat higher gastrointestinal side effects at equivalent dose stages compared to semaglutide alone in head-to-head trials. All three medication categories — Henry’s compounded products, PlexusDx’s compounded protocols, and FDA-approved branded products — carry the same active-ingredient safety profile.

Which one fits — a four-question decision frame

Question 1: Is your priority an all-inclusive subscription with both molecules on one platform? Henry’s $297/month month-to-month injectable semaglutide (with oral tirzepatide tablets available as a 3-month supply) is a clean answer, though PlexusDx Semaglutide Injection ($189/mo) and Tirzepatide Injection ($289/mo) sit below Henry on the lower and middle dose tiers. Question 2: Is total annualized cost the dominant factor? Microdose GLP-1 Protocol at $129/month flat ($1,548/year) saves roughly $2,016/year against Henry. Question 3: Do you want delivery format flexibility — oral, sublingual, or microdose options rather than a weekly injection? PlexusDx offers oral and microdose protocols Henry does not. Question 4: Do you want a genetic baseline informing dose and titration before week one? PlexusDx is the only option in this comparison that includes the Precision Peptide Genetic Test as part of the protocol pathway. If you want comprehensive video-consultation oversight at a flat cash-pay price and don’t need format diversity or genetic stratification, Henry is a reasonable choice. If you want lower entry-tier pricing, format flexibility, or a measurable genetic baseline, a PlexusDx Weight Management Protocol fits more cleanly.

Frequently asked questions

Is Henry a legitimate GLP-1 provider?

Yes. Henry is a legitimate telehealth provider operating since 2023, working with licensed physicians and 503A/503B compounding pharmacies, and serving most U.S. states. PlexusDx Weight Management Protocols use the same regulatory model — licensed U.S. compounding pharmacies, licensed prescribing clinicians, and cash-pay billing — with optional genetic baseline through the Precision Peptide Genetic Test.

How much does Henry cost per month?

Henry charges $297 per month month-to-month for injectable compounded semaglutide, including medication, consultation, and shipping; the 6-month prepaid plan is $1,482 (about $247/month) and the 12-month prepaid plan is $2,364 — the advertised “$197/month” rate, paid in full. Oral tirzepatide tablets are sold as a 3-month supply at $1,047 ($891 paid in full). PlexusDx Microdose GLP-1 Protocol starts at $129/month flat, Semaglutide Injection runs $189/mo, and Tirzepatide Injection runs $289/mo — all below Henry’s $297 month-to-month semaglutide rate.

How long does Henry shipping take?

Henry typically ships within 3–5 business days after prescription approval, using cold-chain shipping for refrigeration-required formulations. PlexusDx ships compounded protocols on a similar timeline through licensed U.S. pharmacies in all 50 states, with 5 states requiring a live consultation before the first prescription rather than async intake.

Can I cancel my Henry subscription?

On Henry’s month-to-month plan, yes — you can cancel before the next billing cycle. On multi-month prepaid plans, Henry’s terms state that cancelling early may require paying out the remaining balance unless you are medically unable to continue treatment. PlexusDx Weight Management Protocols are cash-pay with no membership lock-in — you pay per month for the protocol you’re on, with no separate cancellation fee.

Does Henry offer both semaglutide and tirzepatide?

Yes, in different formats. Henry dispenses compounded semaglutide as a weekly injection ($297/month month-to-month) or sublingual tablet ($249/month), and tirzepatide as an oral dissolving tablet only (3-month supply, $1,047, or $891 paid in full), as of July 2026 — Henry does not offer injectable tirzepatide. The prescribing clinician selects the molecule based on your health profile. PlexusDx offers compounded semaglutide and tirzepatide as injection or oral protocols, plus the GLP-Squared dual-compound stack ($289/mo) for patients whose clinicians select combination therapy.

Does Henry test for genetic factors that affect GLP-1 response?

No. Henry’s standard plan starts titration from population averages and adjusts based on subjective tolerability. PlexusDx is the comparison option that includes the Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) — mapping 48 genes, 57 variants, and 34 weight-management insights including the GIPR rs1800437 variant linked to differential GLP-1 response.

Is Henry covered by insurance?

No. Henry is cash-pay only, with no insurance billing route on the standard plan. PlexusDx is also cash-pay with no membership fee — if your insurance reliably covers Wegovy or Zepbound at a low copay, neither Henry nor PlexusDx is the cost-optimal route, and you should price an FDA-approved branded telehealth provider (Ro, Sesame, Walgreens, or Lilly Direct) instead.

Related reading on PlexusDx: GLP-1 Cost, Semaglutide Cost, Tirzepatide Costs, Cheapest GLP-1.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for Henry is based on Henry’s published rates and checkout flow as captured in July 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.